ADARx Pharmaceuticals, Inc. — Form D
ADARx Pharmaceuticals, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-10. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-10
- Form: D
- Accession: 0001802369-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200.0M
- Amount sold: $200.0M
- Investors: 28
- Date of first sale: 2023-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489353
Issuer
- Name: ADARx Pharmaceuticals, Inc.
- CIK: 0001802369
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 5871 Oberlin Drive, Suite 200, San Diego, CA, 92121
- Phone: 858-283-9472
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Erez Chimovits | Director | NESS ZIONA, L3 |
| Simeon George | Director | Redwood City, CA |
| CARL GORDON | Director | SAN DIEGO, CA |
| Sheila Gujrathi | Director | Boston, MA |
| Lorence Kim | Director | Lexington, MA |
| Judith Li | Director | San Diego, CA |
| Zhen Li | Director | San Diego, CA |
| Yuan (Eliza) Sun | Director | San Diego, CA |
| RICKY SUN | Director | BOSTON, MA |
| CHEN YU | Director | PALO ALTO, CA |
| Zhen Li | Executive Officer | San Diego, CA |
| Rui Zhu | Executive Officer | San Diego, CA |
| Zhen Li | Promoter | San Diego, CA |
| Hongbo Lu | Director | San Diego, CA |
| Xiong Zhang | Director | San Diego, CA |
| Yuan Sun | Director | San Diego, CA |
Other filings by this issuer (6)
More